Table 4. Modification of the Association of Initial Treatment With Subsequent Septorhinoplasty by Diagnosis of Preexisting Nasal Obstruction or Defect.
| Initial Treatment | aOR (95% CI)a | ||
|---|---|---|---|
| No Preexisting Obstruction or Defectb | Preexisting Obstruction or Defectb | Preexisting Obstruction or Defect Within Treatment Strata | |
| Observation | 1.02 (0.89-1.17) | 3.56 (2.80-4.53) | 3.48 (2.79-4.35) |
| Closed | 1 [Reference] | 3.10 (1.93-4.96) | 3.10 (1.93-4.96) |
| Open within 3 wk | 1.76 (1.33-2.32) | 2.02 (1.48-2.77) | 1.15 (0.78-1.69) |
| Open between 3 wk and 6 mo | 1.52 (1.14-2.04) | 1.41 (0.73-2.69) | 0.92 (0.46-1.84) |
Abbreviation: aOR, adjusted odds ratio.
a
Odds ratios are adjusted for age, sex, plan type, region, urban area, year of fracture diagnosis, van Walraven comorbidity index, tobacco use, autoimmune or immunodeficiency disease, anxiety, and turbinate hypertrophy.
b
Preexisting nasal obstruction or defect defined as the diagnosis of deviated septum, nasal obstruction, acquired and congenital deformities of the nose, late effect of fracture of skull and face, and malunion of previous fracture.